Replies to post #17436 on Marker Therapeutics Inc (MRKR)

[Rkmatters]

Yes.

http://www.tapimmune.com/tapimmune-reports-robust-immune-responses-generated-in-19-of-20-evaluable-her2neu-breast-cancer-patients/


And then they presented the final data at the BC symposium last December.